Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
28
NCT02828878
Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2017
Completion: Jul 31, 2020
NCT03260101
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study
Phase: N/A
Start: Jun 10, 2018
Completion: Dec 31, 2021
NCT04006652
ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients
Phase: Phase 1
Role: Collaborator
Start: Dec 16, 2020
Completion: Dec 19, 2022